Login

Stefanini's Co-Entrepreneurship: Partnering for Value | Estanislau Mendes Llobatera Bassols - CEO of Cielo S.A. 00:10:00

Share On Facebook Share On Twitter

Cielo S.A. Has CEO named Estanislau Mendes Llobatera Bassols

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Yext CEO Delivering Brand-verified Information | Michael Walrath, CEO, Yext IncYEXT:NYQ
00:00:00
Dr. Chris Hart, Founder, and Chief Executive Officer, Oventus Medical Ltd
00:10:00
AirAsia CEO Tony Fernandes Reveals Secrets to Building a Multi-Billion Dollar Low-Cost Airline | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
The Marathon of Investing: Parallels Between Running and Financial Planning | B.Gopkumar, CEO , Axis Mutual Fund.
00:10:00
Meet Bobby Daniels: Syverson Strege Team Interview | Bobby Daniels, Financial Planner of Syverson Strege
00:10:00
The partnership between Veracio and Foran | JT Clark - Chief Executive Officer of Veracio
00:10:00
Our mission is to enable our clients to achieve their financial and sustainability goals by providing superior investment returns and solutions | Karin van Baardwijk,Chief Executive Officer,Robeco Capital Gr. Fds. - RobecoSAM Sust. Healthy Living Eqs.
00:10:00
Georges Sarasin Discusses Englobe's Strategic Acquisition of LVMH and Its Impact
00:10:00
XPON Technologies with Proactive at the ASX Small and Mid-Cap Conference | Matt Forman, CEO, XPON Technologies Group LtdXPN:ASX
00:10:00
Importance of Diversifying Custodians for Asset Management
00:10:00
State Management Deep Dive: Redux, NgRx, Signal Store, Context & Zustand | Jo Maes, CEO of Ordina NV
00:10:00
First Helium: Pioneering Publicly Traded Helium Production

© 2026 Nehu